NCT03792971View on ClinicalTrials.gov

Study to Evaluate the Effects of 90 mg Intravenous Infusions of GC4419 on the Single Dose Pharmacokinetics of Dextromethorphan in Healthy Adult Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

13

Participants

Timeline

Start Date

February 10, 2019

Primary Completion Date

February 15, 2019

Study Completion Date

February 15, 2019

Conditions
Healthy
Interventions
DRUG

Dextromethorphan HBr

A single 60 mg dose of DM capsules liquid-filled on Day 1 and Day 3

DRUG

GC4419

Daily 90 mg IV infusions over 60 minutes on Day 3 and Day 4

Trial Locations (1)

33136

Inventiv Health Clinical - Research Pharmacy Unit, Miami

Sponsors
All Listed Sponsors
lead

Galera Therapeutics, Inc.

INDUSTRY

NCT03792971 - Study to Evaluate the Effects of 90 mg Intravenous Infusions of GC4419 on the Single Dose Pharmacokinetics of Dextromethorphan in Healthy Adult Subjects | Biotech Hunter | Biotech Hunter